GKOS  valuation analysis

Basics
Name: Glaukos Corporation
Description: Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. (more)
Industry: Medical Instruments & Supplies
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 25, 2021
Market cap: $3.82B (804th)
Sales(TTM): $224.96M (1346th)
Earnings(TTM): -$120.35M (1189th)

Value
FFER: 4.56 (why)
Actual price: $84.51
FFEThis is Glaukos Corporation's the estimated price. FFEs are the denominator of the FFER ratio.: $18.44
Quantile: GKOS is very expensive given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Glaukos Corporation's earnings decreased from $15.42M to -$120.35M in the last year.
Earnings / MarketCap
Glaukos Corporation
"Medical Instruments & Supplies" industry
Sales / MarketCap
Glaukos Corporation
"Medical Instruments & Supplies" industry
Book / MarketCap
Glaukos Corporation
"Medical Instruments & Supplies" industry
Equity / Assets
Glaukos Corporation
"Medical Instruments & Supplies" industry